Nifty 17196.7 (-1.18%)
Sensex 57696.46 (-1.31%)
Nifty Bank 36197.15 (-0.85%)
Nifty IT 35848.05 (-0.86%)
Nifty Financial Services 17779.5 (-1.13%)
Adani Ports 737.45 (-0.22%)
Asian Paints 3110.45 (-2.21%)
Axis Bank 673.00 (-0.46%)
B P C L 385.90 (1.86%)
Bajaj Auto 3287.85 (-1.22%)
Bajaj Finance 7069.25 (-1.55%)
Bajaj Finserv 17488.70 (-1.52%)
Bharti Airtel 718.35 (-1.94%)
Britannia Inds. 3553.75 (-0.69%)
Cipla 912.05 (-1.00%)
Coal India 159.75 (0.28%)
Divis Lab. 4757.05 (-0.42%)
Dr Reddys Labs 4596.50 (-1.42%)
Eicher Motors 2455.55 (0.16%)
Grasim Inds 1703.90 (-1.16%)
H D F C 2771.65 (-1.29%)
HCL Technologies 1171.40 (-1.12%)
HDFC Bank 1513.55 (-0.80%)
HDFC Life Insur. 690.95 (-2.03%)
Hero Motocorp 2462.45 (-0.41%)
Hind. Unilever 2343.65 (-1.66%)
Hindalco Inds. 424.65 (-1.72%)
I O C L 122.20 (1.28%)
ICICI Bank 716.30 (-0.84%)
IndusInd Bank 951.15 (0.59%)
Infosys 1735.55 (-0.73%)
ITC 221.65 (-1.69%)
JSW Steel 644.55 (-0.34%)
Kotak Mah. Bank 1914.20 (-2.55%)
Larsen & Toubro 1801.25 (0.67%)
M & M 836.95 (-1.48%)
Maruti Suzuki 7208.70 (-1.59%)
Nestle India 19321.35 (-0.93%)
NTPC 127.00 (-1.32%)
O N G C 145.90 (1.32%)
Power Grid Corpn 206.10 (-3.92%)
Reliance Industr 2408.25 (-3.00%)
SBI Life Insuran 1165.95 (-1.86%)
Shree Cement 25914.05 (-1.43%)
St Bk of India 473.15 (-0.81%)
Sun Pharma.Inds. 751.80 (-1.89%)
Tata Consumer 774.30 (0.14%)
Tata Motors 480.10 (0.21%)
Tata Steel 1118.00 (0.50%)
TCS 3640.45 (-0.07%)
Tech Mahindra 1593.30 (-2.23%)
Titan Company 2369.25 (-0.72%)
UltraTech Cem. 7332.45 (0.13%)
UPL 712.75 (2.08%)
Wipro 640.75 (-0.94%)

7 Stocks to Buy This Diwali & Get 20-40% Returns

Diwali Picks 2021
by 5paisa Research Team 28/10/2021

Samvat 2077 has given investors multiple reasons to cheer. Both the benchmark indices – Sensex and Nifty surged over 50% each, gazing beyond the transitory pain arising from the pandemic. Broader markets, however, outperformed the benchmark indices. Unlike previous rallies, retail investors too reveled in this party, as reflected by opening of record number of Demat Accounts. Market performance was driven by factors such as high liquidity, improving economic growth and enhanced profits of India Inc.

As we welcome Samvat 2078, near-term challenges such as surging prices of energy and commodities, higher valuations and possible unwinding of the accommodative monetary policy in both US and India await us. On the flip side, presence of long term catalysts such as continued improvement in the domestic economy and improving earnings growth of India Inc lend comfort. In this scenario, we bring you 7 stocks which could give stellar returns over the next one year.


In this scenario, we bring you 7 Diwali Stocks which could give stellar returns over the next one year.

Diwali Picks 2021 -


CMP (As on Oct 26)

Target Price

Upside (%)

Hindustan Unilever

₹ 2,436.15

₹ 2,950



₹ 690.15

₹ 980


L&T (Larsen & Toubro)

₹ 1,794.45

₹ 2,192


Tech Mahindra

 ₹ 1,562.90

₹ 1,900


Inox Leisure

₹ 419.70

₹ 530


Max Healthcare Institute

₹ 343.70

₹ 475


Bata India

₹ 1,988.85

₹ 2,380



Lets look at these stocks in detail –

1. Hindustan Unilever

CMP (October 26, 2021): Rs. 2,436.15

Target Price: Rs. 2,950

Upside: 21%

HUL needs no introduction. Every Indian uses several products from HUL’s stable ranging across the categories of home and personal care to foods and refreshments. The company is looking to optimize its portfolio and the value offered to customers, besides driving digitalization across its channels. While HUL has a strong reach in every nook and cranny of the country, it is now focusing on hyper-localization through its Win in Many India’s (WiMI) strategy. Focus on premiumization of its brands is likely to augur well for HUL, and resonate well with mid-premium to value consumers. Growing investments in Artifical Intelligence and Machine Learning capabilities will help HUL personalize customers’ experiences while driving cost optimization for distributors and other business partners.


2. HDFC Life

CMP (October 26, 2021): Rs. 690.15

Target Price: Rs. 980

Upside: 42%

HDFC Life Insurance Company, a joint venture between HDFC Ltd. and Standard Life Aberdeen, is a leading private life insurer in India. Growing distribution reach is a key internal growth driver for the company, with highly underpenetrated life insurance market being an external one. Post-acquisition of Exide Life, HDFC Life will become the second largest private life insurer with a market share of ~16.5% in total new business APE (Annualized Premium Equivalent). Improving product portfolio, customer-centricity, solid financial profile and growing protection business will drive the company’s future performance. Rising share of annuity and protection products, coupled with strong operating leverage should support consistent margin expansion for HDFC Life.


3. Larsen & Toubro

CMP (October 26, 2021): Rs. 1,794.45

Target Price: Rs. 2,192

Upside: 22%

Larsen & Toubro or L&T is a large Indian conglomerate present in several sectors including technology, engineering, construction, manufacturing and financial services. It is a proxy play on the Indian economy, given its vast presence in the infrastructure sector. Company has a robust order book and management is confident of strong order inflows in the foreseeable future. Water, Heavy Engineering, Power T&D and Transportation infra are likely to drive order inflows and market share gain for L&T, given the government’s continued emphasis on these segments. L&T’s ability to execute its order book efficiently, reduce working capital, drive cost optimization and leverage digital technologies make it stand out from its competitors. Robust prospects of its IT subsidiaries (L&T Infotech, L&T Technology Services and Mindtree) also augur well for the consolidated entity.


4. Tech Mahindra

CMP (October 26, 2021): Rs. 1,562.90

Target Price: Rs. 1,900

Upside: 22%

Part of the prestigious Mahindra Group, Tech Mahindra is one of India’s leading IT services company. After languishing its peers in terms of growth as well as profitability for quite some time, the company seems to have achieved high visibility and consistency on these fronts. Robust deal wins (especially in key verticals of telecom and enterprise), resilient margins and enhanced capital allocation are some of its key strengths. Management expects to clock in double digit growth in revenues during FY22 and maintain margins at ~15%. The stock, though, continues to trade at a sharp discount to peers (~30%) and can catch up significantly from here on.


5. Inox Leisure

CMP (October 26, 2021): Rs. 419.70

Target Price: Rs. 530

Upside: 26%

Inox Leisure is one of the largest multiplex chains in India and had 156 multiplexes and 658 screens in 70 cities, as of October 2021. The company is one of the worst hit from the pandemic as multiplexes remained closed for the longest time. Hence, it is one of the key beneficiaries from reopening of multiplexes across the country. Inox Leisure plans to take its total screen count to 692 by March 2022. As restrictions around vaccinations ease and good content releases across languages, occupancies and ticket prices can reach pre-pandemic levels. Company is also focusing on non-movie revenues (live sporting events, corporate events, games, etc.) to reduce seasonality of the business. Its strong position and net debt-free balance sheet are some of the other key positives.


6. Max Healthcare Institute

CMP (October 26, 2021): Rs. 343.70

Target Price: Rs. 475

Upside: 38%

Max Healthcare Institute (MHI) is the second largest listed healthcare provider in India and operates 17 healthcare facilities (total 3,400 beds). MHI enjoys dominant position in northern India. The company is also present in preventive & pre/post-hospitalization care at home and diagnostics services segments. Its focus on premium markets (Mumbai, Delhi NCR) augurs well for its Average Revenue Per Occupied Bed (ARPOB). MHI enjoys better ARPOB than peers owing to more number of operational beds. Its plans to add another 1,630 beds by FY28 lend high visibility to future growth. Company is also looking for strategic inorganic opportunities. Overall, it is well placed to capture emerging opportunities in the healthcare space.


7. Bata India

CMP (October 26, 2021): Rs. 1,988.85

Target Price: Rs. 2,380

Upside: 20%

Bata India is one of the oldest players in the Indian footwear market and offers products across all categories (men, women, kids) and price points (mass market to premium). The company’s nationwide footprint (over 1,500 stores) and strong brand recall are its key strengths. Additionally, it has scaled up focus on e-commerce which contributed 15% to FY21 revenues. Its omni-channel solutions provide superior experience to customers. Company’s strategic focus areas include change in product mix towards casual footwear, cost optimization, expanding reach through the asset-light franchisee model and enhancing potential of omni-channel. It is on the right path to improve growth as well as profitability in the future.


Before concluding, I leave you with a thought-provoking quote from none other than the ‘oracle of Omaha’- Warren Buffet: “The stock market is designed to transfer money from the active to the patient.” So, follow a disciplined, patient approach to investments.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Sigachi Industries IPO - 7 Things to Know

Sigachi Industries IPO - 7 Things to Know
by 5paisa Research Team 28/10/2021

The Sigachi Industries IPO Ltd opens on 01-November in the midst of an extremely busy season for primary markets. Sigachi Industries Ltd is a key player in the manufacture of Microcrystalline Cellulose (MCC), which is a widely used excipient used in the finished dosages of formulations in the pharmaceutical industry. Here is a gist of the IPO.

Here are 7 things you need to know about the Sigachi Industries Ltd IPO

1) The product profile of Sigachi Industries Ltd includes MCC of various grades ranging from 15 microns to 250 microns. It currently manufactures 59 different grades of microns across its plants in Hyderabad and in Gujarat.

While one unit is located in Hyderabad, the other two are located in Jhagadia and Dahej in Gujarat.

2) The Sigachi Industries IPO will open on 01-November and close for subscription on 03-November 2021. The IPO price band has been fixed in the range of Rs.161 to Rs.163 with a minimum market lot of 90 shares.

3) The IPO is entirely a fresh issue and there is no OFS component in the IPO. The IPO of Sigachi Industries Ltd will entail the issue of 76.95 lakh shares and at the upper end of the price band of Rs.163, it works out to an issue size of Rs.125.43 crore.

4) The allotment for the IPO will be completed on 10-November while the refunds will be initiated on 11-November. While the shares will be credited to the respective demat accounts on 12-November, the stock will get listed on the NSE and the BSE on the 15th of November.

5) The company is an existing profit making and has been consistently profitable in all the three previous fiscal years. For FY21, Sigachi Industries Ltd reported net profits of Rs.30.26 crore on revenues of Rs.143.95 crore.

That translates into a healthy net profit margin of 21.16% for FY21. It has also reported profits of Rs.9 crore in Jun-21 quarter.

6) Sigachi Industries Ltd has the advantages of an entrenched position in the manufacture of MCC, a long standing market presence, long term and deep relationships with customers, and key strategic locations of its manufacturing plants in proximity to the major demand pockets. 

7) The funds raised by Sigachi Industries Ltd in the IPO would be largely utilized for expanding its footprint. For example, Rs.29 crore would be used to expand MCC capacity at Dahej plant while Rs.30 crore will be used to expand MCC capacity at Jhagadia unit.

Another Rs.33cr will be allocated to manufacture CCS at the proposed unit.

The MCC market is a huge market in India and globally and is likely to keep the demand for the products of Sigachi Industries Ltd ticking.

Also Read:-

List of Upcoming IPOs in 2021

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Nykaa IPO - Subscription Day 1

Nykaa IPO - Subscription Day 1
by 5paisa Research Team 28/10/2021

The Rs.5,352 crore IPO of FSN E-Commerce Ventures (Nykaa), consisting of a fresh issue of Rs.630 crore and an offer for sale or OFS of Rs.4,722 crore, was oversubscribed on Day-1 itself. As per the combined bid details put out by the BSE, FSN E-Commerce Ventures (Nykaa) IPO was subscribed 1.55X overall, with bulk of the demand coming from the retail segment followed by QIB segment. The issue closes on 01st November.

As of close of 28th October, out of the 264.85 lakh shares on offer in the IPO, FSN E-Commerce Ventures (Nykaa) saw bids for 409.73 lakh shares. This implies an overall subscription of 1.55X. The granular break-up of subscriptions were tilted in favour of retail investors but QIBs also participated on the first day of the IPO. QIB bids and NII bids typically come in only on the last day of the IPO.

FSN E-Commerce Ventures (Nykaa) IPO Subscription Day-1



Subscription Status
Qualified Institutional (QIB) 1.39 Times
Non-Institutional (NII) 0.60 Times
Retail Individual 3.50 Times
Others 0.68 Times
Total 1.55  Times


QIB Portion

The QIB portion of the IPO was subscribed 1.39 times at the end of Day-1. On 27 October, FSN E-Commerce Ventures (Nykaa) did an anchor placement of 212.96 lakh shares at the upper end of the price band of Rs.1,125 to 174 anchor investors raising Rs.2,396 crore.

The list of QIB investors including a number of marquee names like Blackrock, Fidelity, Government of Singapore, ADIA, MAS, T Rowe Price, Aberdeen, Goldman Sachs, SBI MF, HDFC MF, ICICI Pru MF, Kotak MF, Tata MF; among others.

The QIB portion (net of anchor allocation as explained above) has a quota of 143.53 lakh shares of which it has got bids for 199.06 lakh shares, implying a subscription ratio of a healthy 1.39X for QIBs at the end of Day-1. QIB bids typically get bunched on the last day, but anchor response at 40 times does show good interest.

HNI / NII Portion

The HNI portion got subscribed 0.60X (getting applications for 42.65 lakh shares against the quota of 71.30 lakh shares). This is a fair response on Day-1 and this segment normally sees response on the last day. That is because, bulk of the funded applications and corporate applications, come in on the last day, so the actual picture should only get better. 

Retail Individuals

The retail portion was subscribed a robust 3.50X at the end of Day-1, showing strong retail appetite. However, it must be noted that retail allocation is just 10% in this IPO. For retail investors; out of the 47.53 lakh shares on offer, valid bids were received for 166.34 lakh shares, which included bids for 132.86 lakh shares at the cut-off price.

The IPO is priced in the band of (Rs.1,085-Rs1,125) and will close for subscription on 01st November 2021.

Also Read About -

Nykaa IPO - 7 Things to know before applying for IPO

Upcoming IPOs in 2021

Nykaa IPO - Information Note

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Reliance fixes Record Date for Paying Final Call on Partly Paid Shares

Reliance Partly Paid Shares
by 5paisa Research Team 28/10/2021

It may be recollected that last year when Reliance had come out with its Rs.53,124 crore rights issue, the allotment money was payable in three tranches over a period of 18 months. As a result, during this period, the Reliance stock had dual trading in the form of fully paid up regular shares and partly-paid up shares. Now RIL has made the call for the last tranche.

Reliance Industries has now fixed 10-November as the record date to determine the holders of partly-paid shares for paying final call amount. Based on the names that appear on the record on 10-November, the holders of partly paid up shares will be required to pay Rs.628.50 per share as the balance amount between 15-November and 29-November.

Once that process is completed, all shares of Reliance Industries outstanding in the market will only be fully paid up shares and the partly paid shares will stand extinguished. The partly paid shares are currently quoting at a discount to the equivalent fully paid up stock. On 09-November, the trading in partly paid up shares will be suspended.

Reliance Industry - Rights Issue

Reliance had come out with the rights issue in May 2020 and allotted a total of 42.26 crore partly paid shares to investors as the first tranche of the rights issue. Only 25% of the amount was payable in the first tranche. The second tranche was made payable as of 11-May, when a call was made for another 25% at a price of Rs.314.25 per share.

The November 2021 call will be the final call for shareholders and will entail payment of the balance 50% of the right issue payment or Rs.628.50 per share. In short while Rs.628.50 was paid in two tranches in Jun-20 and in May-21, the last tranche of Rs.628.50 per share will be payable between 15-November and 29-November.

The last tranche of the rights will be worth a little over Rs.26,000 crore of which the Ambani promoter family itself will pay close to Rs.13,000 crore. As part of the rights issue, the Ambani family had said that they would not forfeit any of their rights and will also be willing to take up any residual rights not taken up by other shareholders. The Ambani family through individuals, PAC and trusts hold 50.61% stake in Reliance Industries.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

One97 Communications (Paytm) IPO - Information Note

One97 Communications (Paytm) IPO - Information Note
by 5paisa Research Team 29/10/2021

Paytm is perhaps one of the most popular digital brands in India, which is why Kontor Brandz had valued the Paytm brand alone at $6.3 billion. That is nearly 35% of the value of Paytm as implied in the IPO. Paytm offers payment services, commerce, cloud services and financial services entirely on a digital mode.

Paytm is a virtual digital universe of its own with over 33.3 crore registered consumers, over 11.7 crore active users each year and over 2.18 crore merchants registered on its platform. Paytm is, in fact, a combination of a consumer and merchant ecosystem with virtual dominance in both. The next big thing for Paytm is the offering of intuitive digital products.

Key terms of the IPO issue of One97 Communications (Paytm)

Key IPO Details


Key IPO Dates


Nature of issue

Book Building

Issue Opens on


Face value of share

Rs.1 per share

Issue Closes on


IPO Price Band

Rs.2,080 - Rs.2,150

Basis of Allotment date


Market Lot


Refund Initiation date


Retail Investment limit

15 Lots (90 shares)

Credit to Demat


Retail limit - Value


IPO Listing date


Fresh Issue Size

Rs.8,300 crore

Pre issue promoter stake


Offer for Sale Size

Rs.10,000 crore

Post issue promoters


Total IPO Size

Rs.18,300 crore

Indicative valuation

Rs.139,379 crore

Listing on


HNI Quota


QIB Quota


Retail Quota



Data Source: IPO Filings

Here are some of the key merits of the One97 Communications (Paytm) business model

i) It has high brand recall, especially beyond the metro and large cities.

ii) It largely dominates the consumer and the merchant ecosystem.

iii) Paytm is the only payment company in India to own each layer of the stack.

iv) It is largely a professionally managed company with no identified promoter group.

v)  Paytm Bank has 6.5 crore accounts, Rs.5,800 crore in deposits and Rs.6,900 crore invested in wealth products. 

vi) For FY21, Paytm had gross market value (GMV) of Rs.400,000 crore with over 740 crore transactions across 12 crore transacting users.

vii) Cross selling across commerce, payments and wallets could be the next big thing to penetrate customer wallets deeper

How is the One97 Communications (Paytm) IPO structured?

The Paytm IPO will be a combination of a fresh issue and an offer for sale. Here is a gist of the IPO offer of the company.

a) The fresh issue component will entail the issue of 386.05 lakh shares and at the peak price band of Rs.2,150 per share, the fresh issue amount will be Rs.8,300 crore. 


b) The OFS component will comprise of the issue of 465.12 lakh shares and at the peak price band of Rs.2,150, the OFS value would be Rs.10,000 crore resulting in a total IPO issue size of Rs.18,300 crore.

c)  Vijay Sekhar Sharma will sell 18.73 lakh shares valued at approximately Rs.402.70 crore. However the four biggest sellers in the OFS will be Antfin Netherlands at Rs.4,704 crore, SAIF at Rs.1,891 crore, SVF Panther at Rs.1,689 crore and at Rs.785 crore.

One97 Communications (Paytm) will be valued at Rs.139,379 crore or at current exchange rates approximately $18.6 billion. This is far lower than what the company was anticipating ahead of the IPO, wherein it was looking at a pricing range of $20-25 billion.

Financials of One97 Communications (Paytm)

Financial Parameters

Fiscal 2020-21

Fiscal 2019-20

Fiscal 2018-19

Sales Revenues

Rs.2,802.40 cr

Rs.3,280.80 cr

Rs.3,232.00 cr


Rs.-1,767.30 cr

Rs.-2,634.40 cr

Rs.-4,366.10 cr

Net Profit / Loss

Rs.-1,701.00 cr

Rs.-2,942.40 cr

Rs.-4,230.90 cr


Data Source: Company RHP

Considering the breadth of investments being made by Paytm in its current and future franchises, the losses are likely to continue. However, there has been a sharp narrowing of losses from Rs.2,942 crore to Rs.1,701 crore. A lot would predicate on how the new initiatives like Paytm Money are able to build on the franchise of the core Paytm.

Check - PayTm IPO - 7 Things to Know

Investment Perspective for One97 Communications (Paytm)

When Zomato was subscribed 39 times despite its size of Rs.9,375 crore, it had raised hopes among digital plays. The response to the Nykaa IPO and Policybazaar IPO will be crucial to the success of the Paytm. Here are few points to note.

A) The current IPO price implies a valuation of $18.6 billion and is just about 20% higher than its last placement. Most digital plays have seen their valuations grow nearly 100% in the last 2  years. That makes Paytm an interesting play on digital India.

B) Paytm has strong dominance over the consumer and the merchant ecosystem and that is likely to favour in its future initiatives. The expansion of ROI can have a multiplier effect on the revenues of Paytm in the coming years.

C) More than 75% of its fresh issue proceeds will go towards strengthening the Paytm ecosystem, inorganic growth, technology investments etc. All these are value accretive for the company.

D) Unique online transacting users are expected to grow from 25 crore to 75 crore in India by 2026. Paytm would be the best positioned to capitalize on this trend.

Above all, it is the penetration in non-urban India and the mindshare that could be the biggest assets for Paytm.

Also Read:- 

Upcoming IPOs in 2021

PB Fintech Policybazaar IPO - Information Note

Fino Payments Bank IPO - Information Note


Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order
Next Article

Dr. Reddy Laboratories and GAIL India Ltd Share Q2 Result

Dr. Reddy Laboratories and GAIL India Ltd Share Q2 Result
by 5paisa Research Team 29/10/2021

Dr. Reddy's Laboratories - Q2 Results

Dr. Reddy's Laboratories Ltd reported stellar numbers for the September 2021 quarter as its top line revenues grew by 17.7% at Rs.4,987 crore. Even on a quarter on quarter basis, the revenues were higher by 17.15%, showing even short term traction in the top line. Here is a gist of the key financials of Dr. Reddy Laboratories.


Rs in Crore






Total Income (Rs cr)

₹ 5,763.20

₹ 4,896.70


₹ 4,919.40


Net Profit (Rs cr)

₹ 992.00

₹ 762.00


₹ 571.00


Diluted EPS (Rs)

₹ 59.65

₹ 45.83


₹ 34.34


Net Margins






What were the triggers for the revenue growth. Let us look at specific verticals. Revenues from the pharma ingredients and the API segment were lower by 2.6% yoy at Rs.999 crore and that was due to supply chain constraints in the business. However, revenues from global generics were up 19% at Rs.4,743 crore and accounted for a bulk of the top line.

Net profits for the Sep-21 quarter were higher by 30.2% at Rs.992 crore. This was on the back of a spurt in the gross margins by 600 bps to 53.4%. Reddy Labs spent Rs.446 crore on  R&D which is 7.7% of sales, and well above the peer group median. EBITDA margins at 27% improved by 600 bps quarter on quarter. India and EM markets showed best growth.

Reddy Labs had a comfortable net debt to equity ratio of 0.015X. Free cash flows stood at Rs.83 crore, which can considered small for a company of that size and scale. Net margins for Reddy Labs at 17.21% was surely better than 15.56% in the Sep-20 year ago quarter and it was sharply better than NPM of 11.6% in Jun-21 quarter.

GAIL India Ltd - Q2 Results

India’s largest gas transportation company, GAIL India, reported 67.39% growth in total revenues for the Sep-21 quarter on consolidated basis at Rs21,782cr. The revenues were higher by 73% on a sequential basis compared to Rs17,589cr revenues in the Jun-21 quarter. There was a volume boost and also a price boost linked to crude oil prices.


Rs in Crore






Total Income (Rs cr)

₹ 21,782

₹ 13,012


₹ 17,589


Net Profit (Rs cr)

₹ 2,883

₹ 1,112


₹ 2,138


Diluted EPS (Rs)

₹ 6.49

₹ 2.47


₹ 4.81


Net Margins







In terms of verticals of GAIL, the major boost to revenues came from the natural gas marketing vertical which was up by 71% at Rs21,011cr. Two other verticals viz.  natural gas transmission and LPG transmission was almost flat on YoY basis. However petchem, liquid hydrocarbons and the CGD business saw good growth in revenues on YoY basis.

Net profits were up 159.34% for the Sep-21 quarter at Rs.2,883 crore. Profits were also higher by 35% on a quarter to quarter basis. The big boost to EBIT came from natural gas marketing which went from an EBIT loss of Rs-335 crore to an EBIT profit of Rs.1,029 crore. That actually triggered the boost to the overall profits to GAIL.

The EBIT contributions of CGD, liquid hydrocarbons and petchem also showed growth like in the case of the top line. However, this was on a much lower base. Net profit margins at 13.24% was substantially superior to 8.54% in the Sep-20 quarter and was also better than the net profit margins of 12.15% in Jun-21 quarter.

Open Demat Account

Enter First Name & Last Name
Enter Mobile Number
Enter correct otp
Please enter referal code
Start investing in just 5 mins
Free Demat account, No conditions apply
  • 0%* Brokerage
  • Flat ₹20 per order